Skip to main content
. 2014 Jan 15;35(6):1320–1329. doi: 10.1093/carcin/bgu011

Fig. 5.

Fig. 5.

Oral administration of GE-Mix also exhibited inhibition of human prostate tumor xenograft growth in nude mice. Male nude mice were subcutaneously injected with 106 PC-3-luc cells. (A) Representative bioluminescent images of one animal per group indicating progression of tumor growth over 4 weeks. (B) Graphical representation of quantitative radiance measured as the number of photons leaving a square centimeter of tissue and radiating into a solid angle of 1 steradian (photons/s/cm2/sr) from vehicle and GE-Mix fed mice for 4 weeks. (C) Tumor growth monitored (by vernier calipers) and presented as tumor volume in cubic millimeter, over a period of 4 weeks. (D) Graphical representation of body weight of vehicle control and GE-Mix treated mice [*P < 0.05 (two-way analysis of variance), as compared with controls; B and C]. Error bars refer to ±SD. Statistical significance in percent tumor growth between control and treatment groups was achieved after week 3.